Why some cancers may respond poorly to key drugs discovered
Patients with BRCA1/2 mutations are at higher risk for breast, ovarian and prostate cancers that…
Browsing: BRCA 1/2-deficient tumours
Trending
- Making Telehealth Human – Podcast
- Sign Up for The Oncology Newsletter | Our free weekly news roundup
- Mapping the paradigm shift of China’s cancer burden for designing prevention strategies
- AACR 2021: Cancer aneuploidy may predict responses to immunotherapy in patients with non-small cell lung cancer
- AACR 2021: Immune-stimulating drug before surgery shows promise in early-stage pancreatic cancer
- AACR 2021: Copanlisib-rituximab combination cuts lymphoma progression or death by nearly half in CHRONOS-3 trial
- AACR 2021: Resistance to immunotherapy in patients with urothelial bladder cancer is traced to specific sets of immune cells
- AACR 2021: Bispecific fusion protein tebentafusp significantly improves overall survival in patients with metastatic uveal melanoma
- Scientists identify potential new target for lung cancer treatment
- Excellent outcomes reported for first targeted therapy for paediatric Hodgkin lymphoma
